The Incidental Economist

The health services research blog


  • About the blog
  • FAQ
  • Podcast archive
  • Site policies
  • TIE-U
  • Masthead

    Editors in Chief
    Austin Frakt twitter facebook email
    Aaron Carroll twitter facebook email

    Managing Editor
    Adrianna McIntyre twitter facebook email

    Contributors
    Kevin Outterson twitter email
    Bill Gardner Google+twitterfacebook email
    Nicholas Bagley twitterfacebook email
    Other Contributors
  • Recent posts

    • Vaccine Development, Covid-19, and mRNA vaccines
    • Incidents and Criticisms: Vaccine Backlash Part 2
    • Home cultivation of medical marijuana can result in higher hospitalizations and emergency department visits related to opioids
    • Healthcare Triage Podcast: Making Progress in Multiple Myeloma Research
    • The History of Vaccine Backlash Part 1
    • HSR Special Issue Call for Abstracts: Translating Research into Policy and Action
    • Cancer Journal: How to Live with Cancer
    • Unemployment Insurance Can Help Reduce Food Insecurity, the More Generous the Better
    • Expanding health coverage is good. But we also need to fix stingy plans.
    • Completely, 100%, removing, killing, disabling, and canceling Google Family Link
  • Archives

  • For speaking inquiries


    Interested in having Aaron or Austin speak to your group?

    For information on Aaron speaking, click here.

    For information on Austin speaking, contact the Leigh Bureau.

  • Aaron’s stuff

    Selected appearances:
    The Colbert Report
    Good Morning America
    Sound Medicine (most recent)
    The Ed Show

  • Austin’s stuff

    Click here for links to Austin’s peer-reviewed publications and/or related posts.

  • CDC Report on Antibacterial Resistance

      09/16/2013
      Kevin Outterson

    The CDC just published a comprehensive threat assessment on antibiotic resistance. The topline results will be sure to grab headlines:

    National_Summary_Data

    Three pathogens make the top-tier “urgent threat” list:

    • Clostridium difficile 
    • Carbapenem-resistant Enterobacteriaceae (CRE)
    • Drug-resistant Neisseria gonorrhoeae 

    MRSA didn’t make the “urgent threat” list for two reasons:

    (1) the number of cases has declined as hospitals have implemented more effective infection control measures (at the urging of CMS and others).  This is good news, demonstrating that reimbursement levers can help improve safety in US hospitals; and

    (2) attracted to the MRSA market, a number of companies have brought antibiotics to the market to fill the gap. This is also good news, as it shows the market working (at least in this instance) in antibiotic R&D. I wish we could say the same for CRE and Neisseria gonorrhoeae. As for Clostridium difficile, the ICAAC conference in Denver last week saw multiple presentations on fecal transplantation, with remarkable early results.

    Disclosure:  I serve on the CDC’s Antimicrobial Resistance Working Group

    @koutterson

    Share this...
    Tweet about this on Twitter
    Twitter
    Share on Facebook
    Facebook
    Email this to someone
    email
     
      Health Policy, Law
    item.php
    • Comments (4)

    • by robert aylward on September 16th, 2013 at 16:49

      As the number of chronic illnesses increases, so too will antibiotic resistance. It’s a heck of a dilemma: risk death from infection now or antibiotic resistance and death from infection later. That’s an anecdotal comment based on my experience with someone with chronic leukemia. And another anecdotal comment about staph. It’s prevalent in my small community, frightfully so. I say frightfully because my grandfather, an army surgeon in both the Spanish American War (in the Philippines) and the Philippine American War that followed, died of staph he had contracted years earlier while serving in the Philippines. A hundred years later and we continue to battle staph.

      [top]
    • by Floccina on September 16th, 2013 at 17:22

      Very important subject. I saw some hope inspiring news regarding c. diff.

      Transplanting feces from a healthy person into the gut of one who is sick can quickly cure severe intestinal infections caused by a dangerous type of bacteria that antibiotics often cannot control.

      A new study finds that such transplants cured 15 of 16 people who had recurring infections with Clostridium difficile bacteria, whereas antibiotics cured only 3 of 13 and 4 of 13 patients in two comparison groups. The treatment appears to work by restoring the gut’s normal balance of bacteria, which fight off C. difficile.

      [top]
    • by Greg on September 17th, 2013 at 09:12

      Based on other new reports, I presume these are numbers of illness and death per year. But, I do not see this information anywhere on the graphic. It is a nice graphic, but it would be useful to tell the reader what the numbers mean.

      [top]
    • by Mark Spohr on September 17th, 2013 at 14:28

      To me, the most significant part of the report was that it finally acknowledged the role of antibiotics on farms in creating resistance. Antibiotics given to animals make up over 90% of antibiotic use and these are often given in low dose which increases the chance of creating resistance. They recommended that farm use be curtailed.
      Of course, the farmers and pharma are all up in arms about this so we shall see how it plays out. Unfortunately, farmers and pharma have lots of money to buy congress so I don’t expect much action.

      [top]

    • Follow the blog

      rss Google+ twitter facebook

      Why all these options?

    • TIE Books


      Bad Food Bible
      Amazon.com
      Barnes & Noble
      Indiebound
      iBooks
      Google
      Kobo


      Dont-Put-That-in-There
      Amazon.com
      Barnes & Noble
      Books-A-Million
      iBooks
      IndieBound
      Powells



      Buy at Amazon.com
      Summary

      Excerpt: Economic profit
      Excerpt: Diminishing marginal utility
      Excerpt: Four factors of production
      Excerpt: Monopoly marginal revenue
      Excerpt: Consumer/producer surplus


      Don't Cross Your Eyes!
      Amazon.com
      Barnes & Noble
      Books-A-Million
      Borders
      IndieBound
      Powells


      Don't Swallow Your Gum!
      Borders
      Barnes & Noble
      IndieBound
      Amazon.com
      Books-A-Million
      Powells

      Austin and Aaron are participants in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazon.com.
    • Tag cloud

      ACA AcademyHealth access accountable care organizations Affordable Care Act announcement blogging cancer comic competitive bidding costs cost shifting COVID-19 employer-sponsored health insurance health care costs Healthcare Triage health insurance health insurance mandates health reform hospital readmissions hospitals insurance exchange market power Massachusetts Medicaid Medicare Medicare Advantage mortality nutrition obesity On The Record opioids physicians politics PPACA premiums prescription drugs quality reading list reflex RWJF spending uninsured Upshot vaccines
    Work posted here under copyright © of the authors.

    Details on the Site Policies page.

    © 2021 The Authors*